Kelly Evans is co-anchor of CNBC's "Closing Bell." She joined the network in February 2012 as an on-air correspondent, reporting across CNBC's business day programming.
Prior to CNBC, Evans was a reporter and columnist for The Wall Street Journal, penning the influential "Ahead of the Tape" column and writing for "Heard on the Street." She also hosted the daily "News Hub" program on WSJ.com and was a frequent guest on television and radio networks, including CNBC. Evans joined the Journal in 2007 as a reporter covering real estate and economics.
Evans graduated magna cum laude with a bachelor's degree from Washington & Lee University in Lexington, Va., where she was a George Washington Honor Scholar, a four-time scholar-athlete, and inducted into the national leadership society, Omicron Delta Kappa.
Follow Kelly Evans on Twitter @Kelly_Evans.
Former CEO Mohamed El-Erian received a bonus of $230 million and co-founder and former CIO Bill Gross walked away with $290 million. John Martini, Reed Smith LLC Partner, and "Shark Tank" investor Kevin O'Leary provide perspective into the board's approval.
Intercept Pharmaceuticals CEO Mark Pruzanski, provides insight to his company's efforts to tackle NASH, or nonalcoholic steatohepatitis, saying over 10 percent of the U.S. population is thought to have NASH. Pruzanski also weighs in on being a public company.